Invesco
ECYT

Invesco’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Invesco’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,350,481
Closed -$24M – 3927
2018
Q3 		$24M Buy
1,350,481
+361,750
+37% +$6.21M 0.01% 1168
2018
Q2 		$13.6M Buy
+988,731
New +$11.7M ﹤0.01% 1481
2016
Q2 		– Sell
-19,397
Closed -$60K – 3757
2016
Q1 		$60K Sell
19,397
-1,359
-7% -$4.44K ﹤0.01% 3653
2015
Q4 		$83K Sell
20,756
-13,093
-39% -$60.3K ﹤0.01% 3666
2015
Q3 		$155K Buy
33,849
+13,617
+67% +$71.3K ﹤0.01% 3638
2015
Q2 		$105K Buy
+20,232
New +$121K ﹤0.01% 3852
2014
Q3 		– Sell
-199,205
Closed -$1.31M – 4133
2014
Q2 		$1.31M Buy
199,205
+100,107
+101% +$1.13M ﹤0.01% 2840
2014
Q1 		$2.36M Buy
99,098
+675
+0.7% +$9.79K ﹤0.01% 2455
2013
Q4 		$1.05M Buy
98,423
+84,434
+604% +$932K ﹤0.01% 3057
2013
Q3 		$186K Sell
13,989
-110,114
-89% -$1.74M ﹤0.01% 3795
2013
Q2 		$1.63M Buy
+124,103
New +$1.67M ﹤0.01% 2525

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Invesco's ECYT Position: Q4 2018 in Review

Invesco sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 1,350,481 shares — an estimated $24M sold.

Invesco first reported a position in ECYT in Q2 2013 and held it in 11 quarters. The position peaked at $24M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Invesco reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Invesco sold 1,350,481 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $24M.
  • Invesco first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
  • Invesco's Endocyte, Inc. Common Stock position peaked at $24M in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Invesco's 13F filing for Q4 2018, filed 14 Feb 2019.